Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Weiss

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Brain : a Journal of Neurology|October 23, 2015
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD ratLaura E Clemens, Jonasz J Weber, Tanja T Wlodkowski, et al.
Oncotarget|March 28, 2020
DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathwayCaroline Dafflon, Swann Gaulis, Louise Barys, et al.
Cancer Research|November 7, 2023
CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung CancerAnirudh Prahallad, Andreas Weiss, Hans Voshol, et al.
Scientific Reports|July 13, 2017
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease modelsManuel Daldin, Valentina Fodale, Cristina Cariulo, et al.
Nature Communications|April 22, 2025
Genetics of circulating proteins in newborn babies at high risk of type 1 diabetesMauro Tutino, Nancy Yiu-Lin Yu, Konstantinos Hatzikotoulas, et al.
Diabetologia|January 30, 2021
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trialRobin Assfalg, Jan Knoop, Kristi L Hoffman, et al.
Diabetes Care|January 21, 2026
Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled TrialAnette-Gabriele Ziegler, Ali Albeer, Stefanie Arnolds, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 13, 2018
Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT ElevationHeiko S Schadt, Armin Wolf, Joerg Andreas Mahl, et al.
Journal of Huntington'S Disease|July 27, 2014
A transgenic minipig model of Huntington's DiseaseMonika Baxa, Marian Hruska-Plochan, Stefan Juhas, et al.
Plos Biology|December 5, 2013
HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegenerationMichal Mielcarek, Christian Landles, Andreas Weiss, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Brain : a Journal of Neurology|October 23, 2015
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD ratLaura E Clemens, Jonasz J Weber, Tanja T Wlodkowski, et al.
Oncotarget|March 28, 2020
DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathwayCaroline Dafflon, Swann Gaulis, Louise Barys, et al.
Cancer Research|November 7, 2023
CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung CancerAnirudh Prahallad, Andreas Weiss, Hans Voshol, et al.
Scientific Reports|July 13, 2017
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease modelsManuel Daldin, Valentina Fodale, Cristina Cariulo, et al.
Nature Communications|April 22, 2025
Genetics of circulating proteins in newborn babies at high risk of type 1 diabetesMauro Tutino, Nancy Yiu-Lin Yu, Konstantinos Hatzikotoulas, et al.
Diabetologia|January 30, 2021
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trialRobin Assfalg, Jan Knoop, Kristi L Hoffman, et al.
Diabetes Care|January 21, 2026
Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled TrialAnette-Gabriele Ziegler, Ali Albeer, Stefanie Arnolds, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 13, 2018
Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT ElevationHeiko S Schadt, Armin Wolf, Joerg Andreas Mahl, et al.
Journal of Huntington'S Disease|July 27, 2014
A transgenic minipig model of Huntington's DiseaseMonika Baxa, Marian Hruska-Plochan, Stefan Juhas, et al.
Plos Biology|December 5, 2013
HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegenerationMichal Mielcarek, Christian Landles, Andreas Weiss, et al.
Pageof 11